Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc. (FUSN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FUSN · as of Jun 8, 2026
Key Statistics
Explore Fusion Pharmaceuticals Inc. Data
fusn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 26.7%
The FUSN analyst consensus is Hold, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $15.25, representing -29.23% downside from the current price of $21.55.
Competitors & Peers
fusn competitorsFUSN
AMAM
ASTH
BLU
CALT
CINCStock Performance
Full HistoryAbout Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc. is a clinical-stage oncology enterprise focused on creating precise radiopharmaceutical therapies. The company utilizes its groundbreaking Targeted Alpha Therapies platform…
what is fusion pharmaceuticals inc. · fusn stock overview · fusion pharmaceuticals inc. company profile · who is fusion pharmaceuticals inc. ceo · fusn NASDAQ · fusion pharmaceuticals inc. headquarters · fusion pharmaceuticals inc. business segments
About Stock Overview & Key Data
Fusion Pharmaceuticals Inc. (FUSN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 26, 2020. As of the latest trading session, FUSN stock price is $21.55, with a market capitalization of $1.8B. The stock has returned +365.44% over the past 12 months and +160.27% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Fusion Pharmaceuticals Inc. stock is Hold, with an average 12-month price target of $15.25. In fiscal year 2023, Fusion Pharmaceuticals Inc. reported revenue of $2.1M and net income of -$94.9M. For detailed data — including Fusion Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fusion Pharmaceuticals Inc. (FUSN) stock price is $21.55. The stock is traded on NASDAQ under the ticker symbol FUSN. The 52-week range is $2.31 – $21.60.